International Transplant Skin Cancer Collaborative
Solid organ transplant recipients are up to 65 times more likely to develop skin cancer than people without transplants. The International Transplant Skin Cancer Collaborative (ITSCC) was founded in 2001 by dermatologists from several institutions in response to this alarming phenomenon of accelerated skin cancer development in solid organ transplant recipients.
- To integrate and support basic scientific and clinical research to address the special needs of transplant recipients with skin cancer in order to improve quality of care.
- To educate patients, scientists, primary care doctors and specialist physicians on the unique needs and clinical care issues in the transplant patients.
October 30, 2013
Deadline: Transplant Skin Cancer Network Call for applications
The American Academy of Dermatology is seeking dermatologists to participate in an effort to study squamous cell carcinoma incidence, metastasis, and mortality among transplant recipients.
Dermatologists currently working with transplant centers to evaluate and treat patients with skin disease, including skin cancer, are encouraged to submit an application. The Academy is providing seed money and facilitating the development of a network of dermatologists paired with transplant centers that will conduct the initial study and be able to seek and secure funding from the NIH and other sources for future research.
Click here for more information.
March 22, 2014
8:00 - 11:00 am
ITSCC Board of Directors Meeting
We are looking at funding opportunities for a transplant skin cancer registry. A knowledge of which transplant centers are associated with our members and a rough idea of how many transplant patients are being followed would be helpful in this process. Please provide us with these brief details regarding your transplant practice. Click here to take survey